bortezomib

Bortezomib was approved for medical use in the United States in 2003 and in Europe in 2004. Bortezomib, sold under the brand name Velcade among others, is an anti-cancer medication used to treat multiple myeloma and mantle cell lymphoma.. Reference standards of Bortezomib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below

stdClass Object
(
    [pname] => 1-Bromo-2-methylpropane
    [catalogue_number] => PA 02 79510
    [category_ids] => ,92,84,
    [chemical_name] => 
    [weight] => 137.02
    [form] => C4H9Br
    [cas] => 78-77-3
    [pslug] => 78-77-3-1-bromo-2-methylpropane-pa0279510
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 02 79510

1-Bromo-2-methylpropane


  • Catalogue No.:PA 02 79510

  • CAS :

    78-77-3

  • Molecular Formula : C4H9Br

  • Molecular Weight : 137.02

CPHI INDIA- 28, 30 November